Post-translational modifications in control of human thyroglobulin
Thyroglobulin is the protein precursor of thyroid hormones, key regulators of vertebrate development and metabolism. On the occasion of World Thyroid Day, Laura Tosatto and Francesca Coscia discuss how post-translational modifications (PTM) of thyroglobulin can regulate thyroid gland function in health and disease. They also highlight the importance of combining structural biology, proteomics, and genomics to identify PTM variations and their implications in different diseases.
The thyroid gland is an endocrine gland where thyroid hormones (THs) are synthetised and then released into the bloodstream to modulate body growth, development, and metabolism in vertebrates. Impairment of TH production in the thyroid is related to several disorders (for example Hashimoto thyroiditis, Graves’ disease, congenital hypothyroidism) which severely affect human well-being.
Thyroglobulin (Tg) is a high molecular mass protein produced by the follicular cells in the thyroid, which serves as an essential TH biosynthetic precursor. Thyroid function and TH production have been suggested to be regulated by a vast array of post-translational modifications (PTMs) decorating the surface of Tg (e.g. phosphorylation, glycosylation, sulfation, acetylation, and iodination).
Francesca Coscia and Laura Tosatto at the HT Structural Biology Research Centre review the different PTMs of human Tg and provide their three-dimensional representation on the recently determined electron cryo-microscopy (cryo-EM) structure of Tg (Coscia et al, Nature 2020). The researchers discuss how different PTMs may affect Tg folding and binding to other proteins, immunogenicity, and TH release. Furthermore, Tosatto and Coscia suggest that a combination of multi-omics, structural and functional data would help categorise patients’ phenotypic mutations linked to altered Tg functions and provide predictive and diagnostic tools for disease-dependent Tg PTMs patterns.
The review is published in the European Thyroid Journal.
Share:
You could also like:
-
Italy at the centre of the Genome of Europe project
The Human Technopole, ELIXIR Italia, the national node of the European life sciences research infrastructure coordinated by the National Research Council (CNR), and the Centro Cardiologico Monzino, as the Italian coordinating centre, have been selected as the Italian partners of Genome of Europe (GoE), the largest EU-funded genomic project, whose ultimate goal is to make […]
-
Human Technopole wins 2024 Oscar di Bilancio
On Friday 13 December, at Palazzo Mezzanotte in Milan, the Human Technopole Foundation’s ‘Integrated Report 2023’ received the Oscar di Bilancio in the social enterprises and non-profit organisations category. The award was presented to President Gianmario Verona, Elena Trovesi, Head of Administration, as well as the project leaders Giovanni Selmi, Head of Finance, and Alessandro […]
-
Mosaic Organoids to Study the Brains of Multiple Patients Simultaneously
An international team of scientists from Human Technopole and the University of Milan has developed and validated an innovative approach to studying human brain development across multiple individuals simultaneously using single organoids—laboratory models that replicate key cellular processes of human neurodevelopment. The research paves the way for in vitro population studies. Additionally, the scientists have developed a novel computational method to more accurately quantify the genetic identity of individual cells profiled from multiple individuals concurrently. The findings have been published in Nature Methods.
-
Cancer stem cell morphology predicts glioblastoma growth and resistance
Human Technopole researchers have identified adducin-γ (ADD3) as a crucial regulator of glioblastoma cancer stem cell morphology and intercellular bridges between tumour cells. These connections facilitate communication and allow tumour cells to share resources, evade chemotherapy, and survive in challenging conditions. The study has been funded by AIRC and the findings are published in Life Science Alliance.
-
Colorectal Cancer: ML Enhances Cetuximab Response Predictions
An international collaborative study led by Human Technopole, Candiolo Cancer Institute IRCCS in Turin, the University of Turin, and the Wellcome Sanger Institute in Cambridge (UK) has identified new factors associated with therapeutic response in colorectal cancer. The research has led to the development of a machine-learning model capable of accurately predicting the effects of cetuximab, a drug in clinical use, on different colorectal tumour subtypes. Funded by the AIRC Foundation, the study paves the way to identifying molecular features that could serve as biomarkers for predicting treatment response in patients with this type of cancer.